Docoh
Loading...

CVSI CV Sciences

News

From Benzinga Pro
Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More
11 Jan 22
Cannabis, News, Health Care, Markets, Interview, General
After the hustle and bustle of the holidays, many people are looking to curtail their consumption of alcohol and are therefore partaking in Dry January.
CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients
11 Jan 22
Cannabis, News, Penny Stocks, Markets
CV Sciences, Inc. (OTCQB: CVSI) is launching +PlusCBD Pain Relief topicals.
Nutrition Giant GNC To Distribute CBD Products In 770 Stores In US
6 Jan 22
Cannabis, News, Penny Stocks, Markets
Hemp cannabidiol (CBD) products maker CV Sciences, Inc. (OTCQB: CVSI) has signed a distribution agreement with health and nutrition-related products behemoth GNC.
Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC
5 Jan 22
Cannabis, News, Penny Stocks, Small Cap, Markets, Trading Ideas
The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI Massachusetts cannabis prices continue to fall Kentucky GOP Sen. Damon Thayer: "Medical cannabis is a slippery slope for recreational marijuana.”
Cantor Fitzgerald Maintains Neutral on CV Sciences, Lowers Price Target to $0.17
10 Dec 21
News, Price Target, Analyst Ratings
Cantor Fitzgerald analyst Pablo Zuanic maintains CV Sciences (OTC:CVSI) with a Neutral and lowers the price target from $0.42 to $0.17.
The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More
19 Nov 21
Cannabis, Earnings, M&A, News, Penny Stocks, Guidance, Health Care, Financing, Small Cap, Exclusives, Markets, Tech, General
Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021. Contents
Trending Up: $TLLTF $VRNOF $UNRV, GOP Cannabis Bill, Cause for Hope? — Cannabis Daily November 16, 2021
16 Nov 21
Cannabis, News, Penny Stocks, Small Cap, Markets, Trading Ideas
The Best Daily Overview Of The Cannabis Space Representative Nancy Mace’s Cannabis Legalization Bill is the talk of the town. On today’s Cannabis Daily, we covered the following public companies:
CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation
15 Nov 21
Cannabis, Earnings, News, Penny Stocks, Politics, Markets, General
CV Sciences, Inc. (OTCQB: CVSI), a supplier and manufacturer of hemp cannabidiol (CBD) products, announced its financial results for the quarter on Monday, Nov 15. Third Quarter 2021 and Recent Financial and Operating Highlights:
Earnings Preview For CV Sciences
12 Nov 21
Earnings
CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate that CV Sciences will likely report an Earnings Per Share (EPS) of $-0.03

Press releases

From Benzinga Pro
Cannabis Industry Investor Conference: Company Executives Present January 19th & 20th
18 Jan 22
News, Press Releases
NEW YORK, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference.
CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals
11 Jan 22
Press Releases, General
SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol ("CBD") products, today
CV Sciences, Inc. Appoints Haskell & White LLP as Auditor
30 Nov 21
News, Contracts, Press Releases
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today
Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028
15 Nov 21
Opinion, Press Releases
- FinancialNewsMedia.com News Commentary - PALM BEACH, Fl., Nov. 15, 2021 /PRNewswire/ -- Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In
CV Sciences, Inc. Announces Convertible Note Financing
15 Nov 21
News, Health Care, Financing, Press Releases
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today
CV Sciences, Inc. Reports Third Quarter 2021 Financial Results
15 Nov 21
Earnings, Health Care, Press Releases
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today